Zhengqing Pharmaceutical Company Group

Hunan Zhengqing Pharmaceutical Group is a leading Chinese pharmaceutical enterprise focused on the integration of Traditional Chinese Medicine (TCM) with modern drug development. The company is widely recognized for its pioneering work with sinomenine, an alkaloid derived from the Sinomenium acutum plant, marketed under the brand name Zhengqing Fengtongning for treating rheumatoid arthritis and related inflammatory conditions. Beyond its flagship rheumatology portfolio, the group maintains a diverse range of products covering pain management, orthopedics, and respiratory health. Zhengqing Pharmaceutical operates comprehensive manufacturing facilities and a dedicated research institute to advance the modernization of herbal medicines through rigorous clinical validation.